Comparison results
Results: Differences Similar | ✘Hemorrhagic vasculitis | ✘Hemorrhagic syndrome | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 51% | — | |||||||
Register, to see more distinctive signs of diseases and studies | — | 90% | |||||||
rheumatism | 30% | — | |||||||
hemorrhagic syndrome | 11% | 100% | |||||||
consequences of suppression | 29% | — | |||||||
hemophilia | — | 89% | |||||||
patient's condition | 20% | — | |||||||
willebrand 's disease | — | 84% | |||||||
erythrocytic cylindruria | 15% | — | |||||||
bleeding | — | 79% | |||||||
need for chocolate | 14% | — | |||||||
hematoma | — | 71% | |||||||
joint pain wandering | 14% | — | |||||||
bruise | — | 71% | |||||||
kidney disease | 14% | — | |||||||
hemarthrosis | — | 70% | |||||||
acute glomerulonephritis | 13% | — | |||||||
munchausen syndrome | — | 70% | |||||||
rash on the buttocks | 13% | — | |||||||
nosebleeds in the afternoon | — | 67% | |||||||
pain in large joints | 13% | — | |||||||
nosebleed in the morning | — | 67% | |||||||
prurigo | 13% | — | |||||||
hemorrhagic diathesis | 12% | 78% | |||||||
papular urticaria | 13% | — | |||||||
blue skin | — | 64% | |||||||
reaction to manta rays | 12% | — | |||||||
dic syndrome | 15% | 75% | |||||||
chronic kidney disease | 12% | — | |||||||
angiopathy | — | 60% | |||||||
rashes symmetrical | 12% | — | |||||||
blood diseases | — | 57% | |||||||
tuberculin | 12% | — | |||||||
vasculitis | — | 56% | |||||||
cylinders | 12% | — | |||||||
bleeding | 13% | 69% | |||||||
nephrotic syndrome | 12% | — | |||||||
intestinal bleeding | 9% | 65% | |||||||
uremia | 11% | — | |||||||
retroperitoneal hematoma | — | 54% | |||||||
glomerulonephritis | 11% | — | |||||||
the skin is black | — | 54% | |||||||
fecal vomiting | 11% | — | |||||||
ulcers in the nose | — | 54% | |||||||
hypercoagulation syndrome | 11% | — | |||||||
thrombocytopenia | — | 52% | |||||||
decrease in gamma globulins | 11% | — | |||||||
angiomatosis | — | 47% | |||||||
stool with blood | 11% | — | |||||||
systemic vasculitis | — | 46% | |||||||
fat deposits | 11% | — | |||||||
nosebleed | — | 45% | |||||||
rash on the limbs | 11% | — | |||||||
consequences of injuries | 11% | 56% | |||||||
wandering pains | 11% | — | |||||||
blood dark | — | 45% | |||||||
chronic glomerulonephritis | 11% | — | |||||||
pretending to be sick | — | 43% | |||||||
rashes bubbles | 11% | — | |||||||
hemorrhages on the skin | 14% | 55% | |||||||
obesity on the stomach | 11% | — | |||||||
gastrointestinal bleeding | — | 40% | |||||||
vaccination | 10% | — | |||||||
injury | 10% | 50% | |||||||
vomiting with blood | 10% | — | |||||||
pus on the tonsils | — | 39% | |||||||
refuses to help | 10% | — | |||||||
sore | — | 39% | |||||||
joint pain | 9% | — | |||||||
arterial bleeding | — | 39% | |||||||
weakening of immunity | 9% | — | |||||||
general tension | — | 38% | |||||||
not sensitive to pain | 9% | — | |||||||
reddening of the skin | — | 36% | |||||||
obesity | 9% | — | |||||||
neurosis | — | 36% | |||||||
pain in the intestines | 9% | — | |||||||
family man | — | 35% | |||||||
nephropathy | 9% | — | |||||||
gradual deterioration of | — | 34% | |||||||
constant pain | 9% | — | |||||||
intestinal insufficiency syndrome | — | 34% | |||||||
proteinuria | 9% | — | |||||||
diseases of the gastrointestinal tract | — | 30% | |||||||
painful appearance | 9% | — | |||||||
inflammation | 9% | 38% | |||||||
protein reduced | 9% | — | |||||||
arthropathy | 11% | 33% | |||||||
brown spots on the skin | 9% | — | |||||||
consequences of infection | 7% | 29% | |||||||
brown pigmentation after rashes | 9% | — | |||||||
hemorrhagic vasculitis | 28% | 50% | |||||||
necrosis | 8% | — | |||||||
red rash | 46% | 63% | |||||||
hematuria | 8% | — | |||||||
petechiae | 49% | 60% | |||||||
papules | 8% | — | |||||||
red dots | 48% | 59% | |||||||
peptic ulcer | 8% | — | |||||||
small-point rash | 45% | 56% | |||||||
acute condition | 8% | — | |||||||
vomiting | 8% | — | |||||||
immunodeficiency | 8% | — | |||||||
subacute condition | 8% | — | |||||||
up circulatory disorders | 8% | — | |||||||
childhood diseases | 7% | — | |||||||
cardiac disorder | 7% | — | |||||||
skin problems | 33% | 29% |
Instructions
Video
|